Follow the people · Insider

LH

Linda T. Hollembaek

Insider · Director · MANH

Linda T. Hollembaek files insider transactions with the SEC as a director of Manhattan Associates. We hold 1 disclosed purchase or sale filed since 21 May 2018, 1 of them in the last 90 days.

  • Files forMANH
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure10 August 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 17 May 20186 August 2026Director · Manhattan Associates 17 Form 4 lines · source: SEC Form 4

Every transaction

17 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
17 of 17 shown
6 Aug 202610 Aug 2026SEC Form 44 dsold on the open marketManhattan Associates1,579 sharesup +8.1%up +5.3%
14 May 202618 May 2026SEC Form 44 dwas grantednot a tradeManhattan Associates1,940 sharesup +59.7%up +50.8%
29 Jul 202531 Jul 2025SEC Form 42 dsold on the open marketManhattan Associates300 sharesdown −8.6%down −6.2%
29 Jul 202531 Jul 2025SEC Form 42 dsold on the open marketManhattan Associates1,724 sharesdown −8.6%down −6.2%
13 May 202515 May 2025SEC Form 42 dwas grantednot a tradeManhattan Associates1,330 sharesup +5.4%up +6.7%
23 May 202428 May 2024SEC Form 45 dwas grantednot a tradeManhattan Associates1,154 sharesdown −8.5%down −8.7%
11 Aug 202314 Aug 2023SEC Form 43 dsold on the open marketManhattan Associates1,800 sharesup +7.7%up +7.1%
11 Aug 202314 Aug 2023SEC Form 43 dgave awaynot a tradeManhattan Associates300 sharesup +7.7%up +7.1%
11 May 202315 May 2023SEC Form 44 dwas grantednot a tradeManhattan Associates1,524 sharesup +20.8%up +19.7%
2 Aug 20223 Aug 2022SEC Form 41 dsold on the open marketManhattan Associates1,000 sharesup +47.9%up +42.2%
12 May 202216 May 2022SEC Form 44 dwas grantednot a tradeManhattan Associates2,079 sharesup +78.5%up +74.7%
10 Aug 202112 Aug 2021SEC Form 42 dsold on the open marketManhattan Associates1,500 sharesup +29.8%up +32.3%
13 May 202117 May 2021SEC Form 44 dwas grantednot a tradeManhattan Associates1,864 sharesup +58.0%up +55.9%
13 May 202117 May 2021SEC Form 44 dwas grantednot a tradeManhattan Associates161 sharesup +58.0%up +55.9%
13 May 202014 May 2020SEC Form 41 dwas grantednot a tradeManhattan Associates3,442 sharesup +195.5%up +188.6%
14 May 201916 May 2019SEC Form 42 dwas grantednot a tradeManhattan Associates3,140 sharesup +222.0%up +209.9%
17 May 201821 May 2018SEC Form 44 dwas grantednot a tradeManhattan Associates3,837 sharesup +373.2%up +370.8%

Both percentages are the stock’s move, not Linda T. Hollembaek’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 17 of the 17 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.